LETI Pharma is a research-based, independent, family-owned biopharmaceutical company. In its different areas of specialization, it seeks to provide society with products that add value to health care.
LETI Pharma has always considered health care as a highly profitable investment and not as an expense to be minimized. Health should not be fundamentally based on the treatment of disease. Taking care of the body, healthy or sick, getting vaccinated and diagnosing diseases on time contributes significantly to improving health and quality of life and reducing the incidence and social cost of disease. Consistent with this philosophy, LETI Pharma offers, in addition to treatments, a wide range of products for disease prevention, early diagnosis and special body care.
Its headquarters are in Barcelona and the plant and the allergy research laboratory are in Tres Cantos (Madrid). It has subsidiaries in Germany (Ismaning and Witten) and in Portugal (Porto). LETI Pharma operates with exclusive distributors in various countries in Europe, Latin America and Africa.
Research and specialization are critical elements in LETI Pharma's strategy. Having innovative and patented products is essential to grow internationally in the chosen market segments. For this reason, LETI Pharma has been dedicating between 10 and 20 percent of its turnover to product research and development.
Our customers trust us
Receive our news